Innophos takes over AMT Labs
AMT is involved in manufacturing mineral ingredients essential to the human diet in the form of chelates as well as custom ingredients for the food, beverage, confectionary and
ReviR Therapeutics has received a rare paediatric disease designation (RPDD) from the US Food and Drug Administration (FDA) for RTX-117, its investigational oral small-molecule therapy for Charcot-Marie-Tooth disease (CMT).
The enhanced version features notable enhancements, particularly integration with the Amcom Mobile Connect encrypted smartphone communications solution. The new version facilitates Emergency Department Discrepancy Module to identify and